Skip to content

MOTS-c vs SLU-PP-332

Updated 8 sources

Key differences

  1. 1SLU-PP-332 is a synthetic small molecule acting on ERR nuclear receptors. MOTS-c is a 16-amino-acid peptide made by mitochondria, acting through AMPK.
  2. 2WADA names MOTS-c on its 2026 List under S4.4. SLU-PP-332 is not named, and at most the catch-all S0 class could apply.

Side by side

Facts from each record, in the same words as their own pages.
MOTS-c and SLU-PP-332 side by side
MOTS-cSLU-PP-332
Category
  • Longevity, Weight loss
  • Weight loss, Longevity
Evidence
  • Animal data only
  • Animal data only
FDA status
  • Not FDA approvedRegulatory
  • Not FDA approvedRegulatory
WADA
  • Prohibited
  • Not confirmed
Half-life
  • Never measured in people. FDA found no in-vivo study, only a lab study showing fast breakdown in human blood. Figures of 1 to 6 hours on other sites are unsourced estimates.Clinical study
  • No half-life published in any species. After a 30 mg/kg injection in mice it was still measurable in plasma and muscle 2 to 6 hours later.Clinical study
  • One guide states about 1.5 hours in mice, without citing a study.Competitor guide
Routes
  • Subcutaneous injection
  • Subcutaneous injection, Oral
Forms
  • Vial (powder)
  • Vial (powder), Tablet, Capsule, Oral solution
Reported doses
  • 0.8 to 10 mg (subcutaneous injection)
  • 200 to 1,000 mcg (subcutaneous injection)
  • 250 to 1,500 mcg (subcutaneous injection)
  • 1 to 10 mg (subcutaneous injection)
  • 5 to 100 mg (oral)
Most cited frequency
  • 2 to 3 times a week
  • Once daily; 500 mcg a day is a common example
Vial sizes
  • 5 mg, 10 mg, 20 mg, 40 mgCompetitor guide
  • 5 mg, 10 mg, 20 mgVendor guide
Mixed vial keeps
  • Fridge, 2 to 8 C, never frozen.Competitor guide
  • Fridge at 2 to 8 °C, protected from light.Competitor guide
Protocols on file
  • 16
  • 7

Doses shown are what sources report, labelled by origin. Not medical advice.

Read each in full

Sources

8 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.

Regulatory3

  1. WADA Prohibited List 2026WADA · checked Oct 24, 2026
  2. FDA briefing document, PCAC July 23 to 24, 2026: MOTS-cFDA · checked Oct 23, 2026
  3. Interim 503A bulks listFDA · checked Oct 24, 2026

Competitor guide2

  1. SLU-PP-332 guide: dosing, reconstitution and ERR agonist research referencepeptidedosingprotocols.com · checked Oct 24, 2026
  2. SLU-PP-332: benefits, dosage, side effects and how the exercise mimetic workspeptidedeck.com · checked Oct 24, 2026